Technology
Health
Medical

Avadel Pharmaceuticals

$1.65
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.05 (-2.94%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell AVDL and other stocks, options, ETFs, and crypto commission-free!

About

Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. It offers Bloxiverz, Vazculep, and Akovaz. Read More The company was founded on December 1, 2015 and is headquartered in Dublin, Ireland.

Employees
180
Headquarters
Dublin, Dublin
Founded
2015
Market Cap
61.57M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
254.42K
High Today
$1.70
Low Today
$1.57
Open Price
$1.70
Volume
52.27K
52 Week High
$7.97
52 Week Low
$1.56

Collections

Technology
Health
Medical
Pharmaceutical
Europe (Non-UK)
Europe

News

StreetInsiderMar 15

Form 10-K AVADEL PHARMACEUTICALS For: Dec 31

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 Commission file number: 000-28508 AVADEL PHARMACEUTICALS PLC (Exact name of registrant as specified in its charter) Ireland 98-1341933 State or other jurisdiction of incorporation or organization (I.R.S. Employer Identification No.) Block 10-1, Blanchardstown Corpor...

29
Seeking AlphaMar 15

Avadel Pharmaceuticals (AVDL) CEO Greg Divis on Q4 2018 Results - Earnings Call Transcript

Avadel Pharmaceuticals (NASDAQ:AVDL) Q4 2018 Earnings Conference Call March 15, 2019 8:30 AM ET Company Participants Greg Divis - CEO Mike Kanan - CFO Geoff Glass - Chairman Conference Call Participants Matt Kaplan - Ladenburg Thalmann Francois Brisebois - Laidlaw Operator Good morning, ladies and gentlemen, thank you for standing by. And welcome to the Avadel Pharmaceuticals’ Fourth Quarter and Full-Year 2018 Financial Results Conference Call. At this time, all participants are in a listen-only m...

56
Yahoo FinanceMar 15

Avadel: 4Q Earnings Snapshot

DUBLIN (AP) _ Avadel Pharmaceuticals PLC (AVDL) on Friday reported a loss of $63.9 million in its fourth quarter. The Dublin-based company said it had a loss of $1.72 per share. The specialty pharmaceutical company posted revenue of $20.9 million in the period. Scroll to continue with content Ad For the year, the company reported a loss of $95.3 million, or $2.55 per share, swinging to a loss in the period. Revenue was reported as $103.3 million. The company's shares closed at $2. A year ago, they were...

47

Earnings

-$2.34
-$1.65
-$0.97
-$0.28
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
-$2.34 per share
Actual
-$0.46 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.